University of California, Davis

Undergraduate Enrollment Intentions and Willingness-to-pay for Online to In-person Teaching Modalities

Retrieved on: 
Monday, November 27, 2023
Research, Climate change, University of California, Davis, Louisiana State University, Student, Journal, Weather, COVID-19, Kansas State University, University, Interview, Communication, Agriculture, Purdue University, Education, Tutoring

MILWAUKEE, Nov. 27, 2023 /PRNewswire-PRWeb/ -- With climate change, extreme weather and natural disasters, short- and long- term shocks to higher education are likely in the future. New research helps to shed light on how administrators and educators can approach these shocks and better understand variations in student preferences and expectations.

Key Points: 
  • New research helps to shed light on how administrators and educators can approach these shocks and better understand variations in student preferences and expectations.
  • Secondly, findings provide insight into undergraduate students' willingness to make tradeoffs, and to pay for, features of campus life during times of disruption.
  • The challenges of COVID-19 show the usefulness of these insights of whether to support campus and residential experiences and asynchronous versus synchronous teaching modalities."
  • If you are interested in setting up an interview, please contact Allison Ware in the AAEA Business Office.

United Imaging Showcases Pioneering Advances and Reinforces U.S. Growth at RSNA 2023

Retrieved on: 
Tuesday, November 21, 2023
RSNA, Yale University, Patient, Huntsman Cancer Institute, MSK, Neurology, Emergency department, Umi, Booth, Biomedical Research, 2D, Diagnosis, Intensive care medicine, Growth, University of California, Davis, Pro, COVID, UVision Air, NCI-designated Cancer Center, Signal-to-noise ratio, Workforce, Heart, Surgery, ATLAS, Software Upgrade Protocol, MRI, Health, AI, Radiology, UC, Christus Health, UMR, FOV, ACS, Radio, University, CT scan, Jupiter, Intelligence, Philosophy, Vision, Brain, Research, Cardiology, ICU, Abdomen, Radiation, Pelvis, FDA, Joint, Workflow, 3D, Medical device, Pharmaceutical industry, Medical imaging, Metaverse, UDR

HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.

Key Points: 
  • HOUSTON, Nov. 21, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is set to showcase its comprehensive portfolio of innovative technologies at RSNA 2023.
  • Highlighting this growth at RSNA 2023, United Imaging will feature the uMR Jupiter 5T (510k pending; not available commercially in the U.S.), a revolutionary whole-body 5T MRI system.
  • In recognition of exceptional scientific contributions, United Imaging takes pride in celebrating Lingzhi (Lance) Hu, Ph.D, a Vice President at United Imaging Healthcare America, who will be honored as a 2023 Distinguished Investigator at RSNA.
  • RSNA attendees are invited to experience the future of medical imaging at Booth #4100, where United Imaging continues to bridge innovation and patient care through state-of-the-art technologies.

Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro™

Retrieved on: 
Monday, November 20, 2023
Radiology, Brain, Medical Device Regulation Act, Alzheimer's disease, Personalized medicine, Disease, DSM-IV codes, Neuro, European, Division, FDA, Neuroradiology, Atrophy, Diagnosis, MRI, University of California, Davis, Certification, Health, UC, Medical device, Medical imaging

GRENOBLE, France, Nov. 20, 2023 /PRNewswire/ -- Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro™, the next-generation AI software for brain MRI analysis that recently demonstrated enhanced detection rates up to 28%1.

Key Points: 
  • GRENOBLE, France, Nov. 20, 2023 /PRNewswire/ -- Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro™, the next-generation AI software for brain MRI analysis that recently demonstrated enhanced detection rates up to 28%1.
  • Pixyl is an award-winning French medtech specializing in AI-powered MRI solutions to improve patient care.
  • "AI-driven MRI analysis opens the possibility of accessing previously unavailable clinically-relevant information to reinforce radiology workflows, especially in the context of neurological disorders."
  • We chose Pixyl to answer our routine practice needs based on their track-record of delivering high-quality brain MRI solutions.

2U Signs 50 New Online Degrees with Six University Partners

Retrieved on: 
Friday, November 10, 2023
Online, Emerson College, Medicine, HPU, Oahu, Master of Science, TWOU, EdX, Education, Creativity, Social work, Master of Professional Studies, Workforce, University of Cape Town, ACPHS, Student, 2U, Public sector, Artificial intelligence, Appetite, Marketing, MSW, Professional studies, Cultural diversity, University, Maryville University, Biomedical sciences, School, MBA, Outline of health sciences, Partnership, Hawaii Pacific University, UNC, King's College London, Mental health, University of California, Davis, UC, Professional, UCT, Master, Dentistry, Tutoring, Nursing, Management, Data science, Optometry, Science, King, Computer security, Pharmacy

LANHAM, Md., Nov. 10, 2023 /PRNewswire/ -- 2U, Inc. (Nasdaq: TWOU), the company behind global online learning platform edX, today announced it has signed contracts with six universities to launch 50 new degree programs under the company's 'flex' degree partnership model, with the majority launching in 2024. The new online degrees will be offered by four new 2U partners–Albany College of Pharmacy and Health Sciences (ACPHS), Hawai'i Pacific University (HPU), King's College London, and Maryville University–and two existing 2U partners, Emerson College and University of Cape Town (UCT).

Key Points: 
  • The new online degrees will be offered by four new 2U partners– Albany College of Pharmacy and Health Sciences (ACPHS) , Hawai'i Pacific University (HPU) , King's College London , and Maryville University –and two existing 2U partners, Emerson College and University of Cape Town (UCT) .
  • "We have unprecedented demand for our flexible partnership model," said Andrew Hermalyn, President of Partnerships at 2U, the company behind edX.
  • Hawai'i Pacific University, a private, nonprofit institution on O'ahu renowned for its exceptional cultural diversity, is expanding its online program portfolio by introducing four master's degrees on edX.
  • Maryville University, a new 2U partner, will launch 47 online education programs on edX, including 28 undergraduate degrees, 11 graduate degrees, five undergraduate certificates, and three graduate certificates.

Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding

Retrieved on: 
Thursday, November 2, 2023
University of California, Davis, Regenerative medicine, California Institute for Regenerative Medicine, UC, Good manufacturing practice, Doctor of Philosophy, Health, BD, Medicine, CGT, Gene, Partnership, University, GMP, CIRM, Point, Patient, Fausto Pocar, POC, Pharmaceutical industry

“Our goal is to facilitate more accessible patient care production through collaboration with aligned expertise.

Key Points: 
  • “Our goal is to facilitate more accessible patient care production through collaboration with aligned expertise.
  • Both parties are interested in expanding on the point of care (POC) network model Orgenesis deploys by aligning the tools, experts, and resources needed to decentralize medical innovation.
  • “We are thrilled to see such a deserving team get support from their state to show the true value of decentralization in California,” Vered Caplan, CEO of Orgenesis commented.
  • To learn more about UC Davis and their pioneering work in the cell and gene therapy industry, please visit: https://health.ucdavis.edu/stemcellresearch/ .

Research Funded by Bay Area Lyme Foundation Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests

Retrieved on: 
Wednesday, November 1, 2023
Linda, Knowledge, Lyme disease, University of California, Davis, Stanford University, Infection, UC, Obesity, MD, University of North Carolina, Doctor of Philosophy, Research, Light, Protein, Duke University School of Medicine, Borrelia burgdorferi, Medicine, Hypertension, Immunotherapy, Bacteria, University, Cell Chemical Biology, Cancer, Hsp90, Cell wall, Patient, Tulane University, DNA, Fatigue, Pharmaceutical industry, Vaccine, Pharmacology

“Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine.

Key Points: 
  • “Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine.
  • He encouraged scientists to take cancer staging techniques and immunotherapy learnings from oncology and apply them to Lyme research.
  • Bay Area Lyme Foundation also funded University of North Carolina collaborator, Matt Redinbo , PhD’s research on HS-291; his lab’s crystallography work was instrumental in the discovery process.
  • Bay Area Lyme Foundation’s research grant program was made possible by the support from the Fairbairn Family, the Younger Family Fund, and Project Lyme .

Neglected Bee Hotels Pose a Threat to Mason Bee Populations: A Fall Cleaning Initiative

Retrieved on: 
Thursday, November 2, 2023
Bee, University of California, Davis, Pollen, Parasitism, UC, Maintenance, Harry Houdini, Honey, Risk, MITES, Sterilization

While millions of bee hotels are purchased each year, many lack the required care and maintenance, jeopardizing bee health.

Key Points: 
  • While millions of bee hotels are purchased each year, many lack the required care and maintenance, jeopardizing bee health.
  • Researchers and industry leaders have observed a rise in predators and parasites, posing a significant threat to mason bee populations.
  • Failing to address this issue could result in bee hotels becoming infested by these predators, endangering mason bee populations.
  • She points out, "Houdini flies and pollen mites are prevalent parasites we encounter in mason bee hotels.

New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

Retrieved on: 
Wednesday, November 1, 2023
Science, University of California, Davis, Korea Disease Control and Prevention Agency, UC, Health, Emeritus, United Nations, Climate, Environmental health, Organization, Doctor of Philosophy, JPA, Environmental Health (journal), Life on Land, Life, Callum Roberts (footballer), Social network analysis, One Health, Proxy, World Health Organization, Communication, Agriculture, Management, Sanitation

WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack of communication and collaboration among influential global stakeholders in human, animal, and environmental health.

Key Points: 
  • One Health stakeholders are talking to themselves and not engaging critical stakeholders across animal, human, and environmental health sectors.
  • This analysis revealed important insights about the One Health approach, including how well the human, animal, and environmental health sectors are communicating.
  • While One Health initiatives have a global impact, the report shows that key players in health, medical, and science fields are not having ongoing and in-depth conversations about One Health.
  • It also highlights limited communication among these stakeholders, underscoring the urgent need for better collaboration to tackle complex global health challenges.

New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

Retrieved on: 
Wednesday, November 1, 2023
Science, University of California, Davis, Korea Disease Control and Prevention Agency, UC, Health, Emeritus, United Nations, Climate, Environmental health, Organization, Doctor of Philosophy, JPA, Environmental Health (journal), Life on Land, Life, Callum Roberts (footballer), Social network analysis, One Health, Proxy, World Health Organization, Communication, Agriculture, Management, Sanitation

WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack of communication and collaboration among influential global stakeholders in human, animal, and environmental health.

Key Points: 
  • One Health stakeholders are talking to themselves and not engaging critical stakeholders across animal, human, and environmental health sectors.
  • This analysis revealed important insights about the One Health approach, including how well the human, animal, and environmental health sectors are communicating.
  • While One Health initiatives have a global impact, the report shows that key players in health, medical, and science fields are not having ongoing and in-depth conversations about One Health.
  • It also highlights limited communication among these stakeholders, underscoring the urgent need for better collaboration to tackle complex global health challenges.

Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Soci

Retrieved on: 
Monday, October 23, 2023
Patient, PD-L1, University of California, Davis, NSCLC, ESMO, Progression-free survival, UC, SCCHN, Pembrolizumab, Congress, Head, MD, PFS, PD-1, Neck, Poster, Non-small-cell lung cancer, Squamous-cell carcinoma, Melanoma, Safety, Toxicity, Pharmaceutical industry

Jonathan Riess, MD, lead investigator of the trial at the UC Davis Comprehensive Cancer Center, shared encouraging clinical and biomarker data from patients with metastatic non-small cell lung cancer (NSCLC) with PD-L1 TPS ≥ 50% and recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) with PD-L1 CPS ≥ 20.

Key Points: 
  • Jonathan Riess, MD, lead investigator of the trial at the UC Davis Comprehensive Cancer Center, shared encouraging clinical and biomarker data from patients with metastatic non-small cell lung cancer (NSCLC) with PD-L1 TPS ≥ 50% and recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) with PD-L1 CPS ≥ 20.
  • Dr. Riess commented, “These preliminary data further support the potential of combining IO102-IO103 and pembrolizumab in patients with metastatic NSCLC and recurrent/metastatic SCCHN.
  • The trial is ongoing and continuing to enroll patients in both cohorts.
  • Poster title: A Phase 2 trial of the IO102-IO103 vaccine plus pembrolizumab: preliminary analysis for first line (1L) treatment of Non-Small Cell Lung Cancer (NSCLC) and Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    The poster will be available on the “ Posters & Publications ” page of the IO Biotech website.